£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

Systemic Cephalosporin Antibiotic Market Outlook 2016-2021 US

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £595 Days at Price

Price Analysis

Most common price: £595 (38 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 38 days

Description

This econometric study provides a comprehensive analysis of latent demand for systemic broad- and medium-spectrum antibiotic cephalosporins across the United States market. The report delivers potential industry earnings (P.I.E.) estimates across approximately 12,700 cities, enabling readers to assess market opportunity at the municipal level with precision. Each city analysis includes percentage share calculations relative to its state and the nation as a whole, creating actionable comparative benchmarks for distribution and sales strategy. The statistical methodology supports informed decision-making for pharmaceutical distributors, sales organisations, and market planners seeking to understand regional demand patterns and competitive positioning within the cephalosporin antibiotic sector. The data-driven approach allows stakeholders to identify high-opportunity markets and optimise resource allocation based on documented latent demand figures.

Key Features

Covers latent demand forecasts for systemic broad- and medium-spectrum antibiotic cephalosporins across all United States regions from 2016 to 2021.

Includes potential industry earnings (P.I.E.) estimates for approximately 12,700 cities, enabling detailed market assessment at the municipal level.

Provides percentage share calculations for each city relative to its state and the United States overall, supporting competitive benchmarking.

Delivers statistical analysis designed for pharmaceutical distribution and sales planning in the cephalosporin antibiotic market.

Published by ICON Group International, Inc. as an econometric market research resource for business planning.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 September 2015
Listed Since
07 April 2016

Similar Products You Might Like

2016-2021 US Antibiotic Pharmaceutical Market Outlook Study
96% match

2016-2021 US Antibiotic Pharmaceutical Market Outlook Study

£595.00 28 Sep 2026
The 2016-2021 Outlook for Systemic Broad- And Medium-Spectrum Antibiotic Erythromycins in the United States
96% match

The 2016-2021 Outlook for Systemic Broad- And Medium-Spectrum Antibiotic Erythromycins in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Synthetic Antispasmodics and Anticholinergics Pharmaceutical Preparations in the United States
91% match

The 2016-2021 Outlook for Synthetic Antispasmodics and Anticholinergics Pharmaceutical Preparations in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Intranasal Drug Delivery Applications in the United States
90% match

The 2016-2021 Outlook for Intranasal Drug Delivery Applications in the United States

£595.00 27 Sep 2026
The 2016-2021 Outlook for Inflammatory Bowel Disease Therapeutics in the United States
90% match

The 2016-2021 Outlook for Inflammatory Bowel Disease Therapeutics in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Medical Sterilization Systems and Equipment in the United States
90% match

The 2016-2021 Outlook for Medical Sterilization Systems and Equipment in the United States

£595.00 27 Sep 2026
2016-2021 Vitamins Outlook United States - Market Demand Study
89% match

2016-2021 Vitamins Outlook United States - Market Demand Study

£595.00 28 Sep 2026
The 2016-2021 Outlook for Non-Prescription Cough and Cold Lozenges in the United States
89% match

The 2016-2021 Outlook for Non-Prescription Cough and Cold Lozenges in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Sanitary Protection Products in the United States
89% match

The 2016-2021 Outlook for Sanitary Protection Products in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Clinical Chemistry Analyzers and Reagents in the United States
89% match

The 2016-2021 Outlook for Clinical Chemistry Analyzers and Reagents in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in the United States
89% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Household Disinfectants in the United States
89% match

The 2016-2021 Outlook for Household Disinfectants in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Psoriasis Drugs in the United States
89% match

The 2016-2021 Outlook for Psoriasis Drugs in the United States

£595.00 27 Sep 2026
The 2016-2021 Outlook for Softphones in the United States
89% match

The 2016-2021 Outlook for Softphones in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Rauwolfia-Alkaloid Preparation and Rauwolfia-Diuretic Combination Hypotensive Pharmaceuticals in the United States
89% match

The 2016-2021 Outlook for Rauwolfia-Alkaloid Preparation and Rauwolfia-Diuretic Combination Hypotensive Pharmaceuticals in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for First Aid Products in the United States
89% match

The 2016-2021 Outlook for First Aid Products in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Plasmapheresis Products in the United States
89% match

The 2016-2021 Outlook for Plasmapheresis Products in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Prescription Barbituate Anxiolytic and Hypnotic Sedatives in the United States
89% match

The 2016-2021 Outlook for Prescription Barbituate Anxiolytic and Hypnotic Sedatives in the United States

£595.00 28 Sep 2026
2016-2021 Medical Hypodermic Needles Outlook - US Market
89% match

2016-2021 Medical Hypodermic Needles Outlook - US Market

£595.00 28 Sep 2026
The 2016-2021 Outlook for Monoclonal Antibody (MAb)-Based Products in the United States
89% match

The 2016-2021 Outlook for Monoclonal Antibody (MAb)-Based Products in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Medical Device Electrodes in the United States
89% match

The 2016-2021 Outlook for Medical Device Electrodes in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Prescription Eyeglass Lenses in the United States
89% match

The 2016-2021 Outlook for Prescription Eyeglass Lenses in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Toilet Soaps in the United States
88% match

The 2016-2021 Outlook for Toilet Soaps in the United States

£595.00 28 Sep 2026
The 2016-2021 Outlook for Household Consumer Durables in the United States
88% match

The 2016-2021 Outlook for Household Consumer Durables in the United States

£595.00 28 Sep 2026